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1. Introduction
Until recently, clinicians concerned about diastolic
blood pressure and peripheral vascular resistance have
tended to suppress the importance of the systolic blood
pressure and of arterial stiffness. However, increased
peripheral vascular resistance, resulting from a reduc-
tion in the calibre and:or number of small arteries and
arterioles, is only one characteristic of the functional
components of the arterial system and does not repre-
sent an adequate description of the vascular impedance
load [1,2].
Some of the most frequent clinical problems in cardi-
ology, such as hypertension and atherosclerosis, result
from derangement of vascular mechanics. For the clini-
cian, however, it is hard to understand the more com-
plex concepts of haemodynamics and the mechanical
principles of arterial disease [3,4].
2. Vascular mechanics
From a conceptual and physiological point of view,
arteries have two different functions that are tightly
related [5–7]. One, the conduit function, describes the
capacity of the arterial system to deliver an adequate
supply of blood from the heart to body tissues. To
maintain this supply, the blood flow (and the mean
blood pressure) must be steady and high enough to
overcome any significant peripheral resistance. The
other, the cushioning function of arteries (see Fig. 1),
results from the capacity of large arteries to buffer
intermittent pulsatile output and accommodate the
blood volume ejected in systole, as well as draining this
volume in a continuous steady flow into smaller arteries
during diastole. This property (‘Windkessel’ or reser-
voir effect) is closely related to the viscoelastic proper-
ties of arterial walls and may be described in terms of
compliance or distensibility.
In physiology, compliance (C) is defined as the abso-
lute diameter (or area) change of an artery for a given
pressure step at a fixed vessel length — dD:dP (cm:
mmHg or cm2:mmHg). Distensibility (Di) is the inverse
of elastic modulus — dD:dPD (mmHg1) — and is
the measure of relative arterial compliance that corre-
lates the relative change in diameter to the imposed
pressure step.
Many other terms may be used to quantify the elastic
properties of the arteries [4]. All of them are site
specific, depending on the intrinsic characteristics of the
arteries and on the mean pressure at which they are
calculated. In the same artery, they may also depend on
the distending pressures to which they are subjected
and on the structure and functional status of vascular
smooth muscle of arterial media [2]. They may be
calculated, directly or indirectly, from the evaluation of
arterial pressure, diameter, flow, and wall thickness [1].
In the last few years, the development of non-inva-
sive techniques of ultrasonography and aplanation
tonomery (sphygmocardiography) has allowed a re-
newed interest in the study of arterial properties [7].
As a consequence of two different functions of arter-
ies, the arterial pressure has two components: one, the
steady component, represented by mean blood pressure;
and the other, the pulsatile component, related to the
oscillation around mean blood pressure and represented
by pulse pressure. The mean blood pressure depends on
cardiac output and on the cross-sectional area and
number or arterioles and small arteries. The pulse
pressure, in turn, depends on the characteristics of left
ventricular ejection, on arterial stiffness, and on the
timing of arterial reflection.
There is another important haemodynamic concept
to remember: The reflection of the arterial wave is a
natural consequence of vascular design [2,8]. The prox-
imal aorta and its major branches behave as long,
highly compliant, arterial vessels that terminate
abruptly in small, less compliant, distal vessels. These
distal vessels are very important to circulatory regula-
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Fig. 1. The cushioning function of arteries.
tion because they account for the generation of an echo
(reflected) wave that travels back towards the heart.
In healthy young people with high aortic compliance,
distensible arteries, and low pulse wave velocity (PWV),
the wave reflection occurs late during early diastole and
after ventricular ejection has stopped. This is physiolog-
ically advantageous to maintain a normal cardiac func-
tion and coronary perfusion pressure during all of
diastole.
Pulse wave velocity (a), the speed of travel of the
pulse along the arterial segment — distance:t (cm:s) —
depends on the arterial stiffness and determines how
quickly the reflected wave echo returns [8]. So, when
there is an increase in PWV or shortening in the
effective arterial length, there is a consequent early
return of wave reflection from the periphery to the
heart. This early return boosts the aortic (and ventricu-
lar) pressure in late systole; increases mean-, peak-, and
end-systolic blood pressure; and reduces the mean aor-
tic pressure during diastole. On the other hand, my-
ocardial work load and oxygen consumption increases.
Finally, increases in systolic blood pressure and pulse
pressure intensify degenerative changes, arterial dam-
age, and arterial stiffening, thus contributing to the
establishment of a deleterious vicious cycle [2].
The decrease in arterial compliance may, therefore,
be a passive consequence of an increase in blood pres-
sure — reduced arterial compliance is frequently ac-
cepted as a feature of hypertension — or the result of
structural and:or functional alterations in the arterial
wall that may occur in several metabolic diseases. How-
ever, in metabolic conditions frequently associated with
hypertension (obesity, diabetes, insulin resistance and
hyperlipidemias), the data on possible changes in
haemodynamics parameters are scarce and frequently
controversial [9].
3. Arterial compliance and atherosclerosis
Cameron et al. [10], tried to study the effect of serum
lipids on systemic arterial compliance in a group of
patients with newly diagnosed coronary artery disease
(meaning that they had not started modifications of
their lifestyle or dietary habits) and in matched con-
trols. They showed a significant negative correlation
between arterial compliance and low-density lipo-
protein (LDL)-cholesterol blood levels. In patients with
coronary disease, there was more severe change in
aortic mechanical properties than in disease-free sub-
jects, despite identical lipid plasma levels in the two
groups. Other authors have also shown the importance
of the amount and severity of coronary atherosclerosis
for the expression of a more generalised disease in the
aorta and in its major branches — with the expected
consequences in the viscoelastic properties of larger
arteries. Barenbrock et al. [11], demonstrated that arte-
rial distensibility was markedly affected only in patients
with severe atherosclerotic disease. Patients with mod-
erate hypercholesterolemia, with no evidence of clinical
atherosclerosis, seem to have a low risk of developing
impaired arterial compliance.
However, recently, Giannattasio et al. [12], showed
that isobaric compliance and distensibility of middle-
sized conduit arteries were significantly reduced in hy-
pertensive patients with mild hypercholesterolemia and
in non-hypertensive hypercholesterolemic patients. The
same authors have found that heterozygous familial
hypercholesterolemia (FH) is associated with a striking
reduction (53.5%; PB0.01) in radial artery compli-
ance compared to normotensive normocholestemlemic
healthy subjects [13].
Surprisingly, in hypercholesterolemic patients with
no apparent genetic lipid abnormality, the arterial com-
pliance was similar to normocholesterolemic controls
[14]. Apparently, there is no explanation for this differ-
ence. The authors suggest the existence of a factor that
disturbs normal endothelial function or modifies the
normal structure and the viscoelastics properties of the
arterial wall. We can speculate that this difference in
the arterial compliance might be related to the coexis-
tence of other eventual genetic factors or with potential
gene–gene interactions.
It is important to remember that genetic and experi-
mental studies have related the renin-angiotensin sys-
tem and angiotensin-converting enzyme (ACE):
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angiotensin II type I (AT1) receptor polymorphisms to
large-artery damage, aortic stiffness and changes in
extracellular matrix [9,15]. O’Malley et al. [16], showed
that ACE DD genotype is associated with an increased
risk for premature development of coronary athero-
sclerosis and myocardial infarction in patients with
heterozygous FH. These investigators have not pon-
dered the possibility that a change in vascular haemo-
dynamics might contribute to an increase in risk. This
certainly will be one of the fields worth further investi-
gation.
Some studies are less explicit about the effect of FH,
hypercholesterolemia, and atherosclerosis in the arterial
compliance. Others present conflicting results on the
effects of hyperlipidemia and other major cardiovascu-
lar risk factors in vascular haemodynamics. Atheroscle-
rosis, in contrast to arteriosclerosis (stiffening and
dilatation of major arteries), is normally accepted as an
example of a focal vascular disease that predominantly
affects conduit function. However, mechanical stress in
the arterial wall may be an important element in
atherogenesis and in the development of atherosclerotic
plaque. It is also involved in plaque rupture. Further,
the type of blood flow is an important determinant for
the organisation of thrombus [17].
Pathologically, the atherosclerotic changes of the ar-
terial wall include an increase in wall thickness and
deposition of lipids (with xanthomatous lesions in FH)
in the intima, smooth muscle cell (SMC) proliferation
with macrophage- and SMC-derived foam cell forma-
tion (presence of extensive fat vacuolation of SMC in
FH), as well as excessive synthesis and accumulation of
fibrillary and non fibrillary connective tissue elements
(collagen, elastin and proteoglycans) [18,19].
4. Discussion
All these morphological changes can modify the vis-
coelastic properties and the buffering capacity of larger
arteries, but their importance may depend on the stage
of the disease. In the early stages of atherosclerosis in
animals where there is a greater accumulation of
cholesterol and foam cells in the intima, the aorta is
more distensible than normal, only to stiffen later when
collagen and calcium predominate in the arterial wall
[20].
Hopefully, long term aggressive LDL-cholesterol re-
duction with statins in patients with polygenic hyper-
cholesterolemia and heterozygous FH with or without
coronary heart disease, can slow the development of
atherosclerosis and improve the progressive stiffness of
larger arteries with potential benefits in cardiovascular
haemodynamics and in cardiac function [13,21–23].
The data on this subject are limited. Explanations
and extrapolations must be made with caution. How-
ever, current non-invasive modern technology for the
analysis of arterial compliance and PWV may poten-
tially be a useful research tool in the study of patients
with familial hypercholesterolemia and a greater sus-
ceptibility to atheroma.
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